Modeling a disease-correlated tubulin mutation in budding yeast reveals insight into MAP-mediated dynein function.

Mutations in the genes that encode α- and β-tubulin underlie many neurological diseases, most notably malformations in cortical development. In addition to revealing the molecular basis for disease etiology, studying such mutations can provide insight into microtubule function and the role of the large family of microtubule effectors. In this study, we use budding yeast to model one such mutation-Gly436Arg in α-tubulin, which is causative of malformations in cortical development-in order to understand how it impacts microtubule function in a simple eukaryotic system. Using a combination of in vitro and in vivo methodologies, including live cell imaging and electron tomography, we find that the mutant tubulin is incorporated into microtubules, causes a shift in α-tubulin isotype usage, and dramatically enhances dynein activity, which leads to spindle-positioning defects. We find that the basis for the latter phenotype is an impaired interaction between She1-a dynein inhibitor-and the mutant microtubules. In addition to revealing the natural balance of α-tubulin isotype utilization in cells, our results provide evidence of an impaired interaction between microtubules and a dynein regulator as a consequence of a tubulin mutation and sheds light on a mechanism that may be causative of neurodevelopmental diseases.

INTRODUCTION

Microtubules and their effectors play numerous critical roles during the life of a cell. For example, in addition to providing tracks for polarized motor-mediated vesicular transport, they comprise the mitotic spindle and are key effectors of nuclear and neuronal migration during early brain development. As a consequence of their myriad cellular roles, it is unsurprising that mutations in the genes that encode α- and β-tubulin and many microtubule-associated proteins (MAPs) are causative of human diseases, with those correlating with tubulin mutations known as tubulinopathies. Most prominent among them are neurological diseases, such as the malformations of cortical development (MCD) family of developmental brain disorders (Bahi-Buisson and Cavallin, 1993; Jaglin ; Poirier , 2013; Breuss ; Cushion ; Di Donato ; Fourel and Boscheron, 2020). MCD diseases (e.g., lissencephaly, pachygyria, and polymicrogyria), which are characterized by severe brain malformations, are largely a consequence of defective neuronal migration in the developing brain.

Mutations in TUBA1A (tubulin α-subunit 1A isoform), which encodes a common α-tubulin isoform expressed in mammalian cells, account for most tubulinopathies and for 4–5% of all lissencephaly cases (Morris-Rosendahl ; Di Donato ). A total of 121 unique heterozygous diseasecausing mutations have been identified in TUBA1A, of which only 15 were found in more than one patient, with the remaining 106 identified only in individuals (Hebebrand ). Although the molecular basis for disease etiology in most patients remains unknown, a recent study predicted that the majority of mutations compromise protein folding and interaction with effectors (Hebebrand ). In addition to providing insight into disease pathology, studying such mutations can reveal molecular insight into the cellular role of microtubules and their effectors (Fourel and Boscheron, 2020).

One residue that is mutated in at least two patients (both of whom are heterozygous for the mutation) is glycine 436 (to an arginine or aspartate), which maps to a region that is directly adjacent to the unstructured C-terminal domain of α-tubulin, a region that is important for interactions with a wide range of MAPs that are critical for various microtubule processes (Bahi-Buisson ; Hebebrand ; Fourel and Boscheron, 2020). The unstructured C-termini of α- and β-tubulin are enriched in negatively charged amino acids, most commonly glutamate (see Figure 1B). These acidic tubulin “tails” (also known as “E-hooks” for their enrichment in glutamates) are required for the normal binding and function of numerous MAPs, including kinetochore-associated factors (e.g., Ndc80, Dam1) (Westermann ; Ciferri ), microtubule effectors (e.g., spastin, XMAP215) (Brouhard ; Eckert ), end-binding proteins (e.g., Bik1/CLIP-170) (Bieling ; Caudron ), and molecular motors (e.g., kinesin, dynein) (Sirajuddin ). Given the proximity of G436R to the α-tubulin E-hook, we reasoned that this mutation might disrupt microtubule function in part by perturbing this region. Thus, we chose to employ a simple model system to assess the consequences of this mutation on microtubule function.

FIGURE 1:

The α-tubulin G437R mutant is a polymerization-competent tubulin in yeast. (A) Structural model of the microtubule lattice with Gly436 indicated (red circle). A cartoon of the unstructured C-terminal tail (in cyan) is included on the right (the model is derived from PDB 3J6G [ Alushin ]). (B) Alignment of the C-terminal region of α-tubulin from various species. The red box delineates a conserved region of small, hydrophobic residues that immediately precedes the C-terminal tail, and the red asterisk indicates Gly436. (C) Representative fluorescence images of yeast cells with the indicated genotype at different stages of their cell cycle (as determined from cell and spindle morphology). Scale bar, 5 µm. (D) Growth assay with haploid cells of the indicated genotype incubated on rich media (YPAD) with or without the indicated concentration of benomyl, a microtubule-destabilizing drug.

Studying tubulin mutations in mammalian cells is complicated by the fact that numerous isoforms of α- and β-tubulin are present in the human genome (nine α-tubulin, and ten β-tubulin isoforms) (Khodiyar ; Findeisen ). Each of these has a distinct expression pattern, and thus every cell’s tubulin content is a composite mixture of these many variants. In contrast to higher eukaryotes, things are much simpler in the budding yeast Saccharomyces cerevisiae in which ∼70–90% of α-tubulin has been reported to be expressed from the essential TUB1 gene, with the remaining ∼10–30% arising from the TUB3 gene (Schatz ; Bode ; Gartz Hanson ). In addition to its simplicity, the mechanisms and effectors of spindle orientation (e.g., dynein, LIS1) and microtubule dynamics and function (e.g., tubulin, EB1, CLIP-170, ChTOG) are highly conserved between humans and budding yeast. In this organism, it is critical that the mitotic spindle is correctly oriented along the mother–bud axis and positioned in close proximity to the bud neck before mitotic exit; otherwise cell viability is compromised. The importance of these processes for cell viability permitted the use of genetic screens that revealed the presence of two distinct pathways that affect spindle orientation and position: namely, the Kar9/actomyosin and dynein pathways (Miller and Rose, 1998). The Kar9/actomyosin pathway relies on a microtubule guidance mechanism, whereby a microtubule plus end–associated myosin (Myo2) orients the mitotic spindle along the mother–bud axis (Lee ; Yin ; Hwang ). Myo2 is recruited to microtubule plus ends by the concerted effort of Kar9 (homologue of human adenomatous polyposis coli tumor suppressor; APC) and the autonomous microtubule plus end–tracking protein, Bim1 (homologue of human EB1). Recently, we have modeled the disease-correlated TUBB2B F265L β-tubulin mutation in budding yeast and found that this mutation specifically compromises the Kar9/actomyosin pathway by disrupting the plus end localization of Bim1 (Denarier ).

Cytoplasmic dynein, on the other hand, functions from the cell cortex, from where Num1-anchored motors walk along microtubules emanating from spindle pole bodies (SPBs, the equivalent of centrosomes), which results in the positioning of the preanaphase spindle at the mother–bud neck (Li ; Carminati and Stearns, 1997; Heil-Chapdelaine ). Dynein is delivered to Num1 receptor sites at the bud cortex by a two-step “offloading” mechanism: 1) microtubule plus end–associated Bik1 (homologue of human CLIP170) recruits dynein-Pac1 (homologue of human Lis1) complexes to dynamic plus ends (Lee ; Sheeman ; Badin-Larcon ; Caudron ); 2) plus end–associated dynein, which appears to be inactive (Lammers and Markus, 2015), is delivered, or “offloaded,” to cortical Num1 receptor sites along with its effector complex, dynactin (Markus and Lee, 2011). Dynein activity is largely governed by its localization to these sites; however, at least one known MAP also regulates dynein activity in yeast: She1. The precise mechanism by which it does so in cells is currently unclear; however, in vitro studies show that She1 can reduce dynein velocity through simultaneous interactions with both microtubules and dynein (Ecklund ), whereas live cell studies have shown that She1 plays a role in polarizing dynein-mediated spindle movements toward the daughter cell (Markus ), perhaps in part by tuning dynactin recruitment to plus end–associated dynein (Woodruff ; Markus ). Of note, She1 binding to microtubules, and its effects on dynein motility, also requires the tubulin E-hooks (Markus ; Ecklund ).

To gain insight into the role and importance of α-tubulin G436 (hereafter referred to as G437, due to its position in yeast α-tubulin) and how it might affect the above processes, we produced S. cerevisiae yeast strains in which the native TUB1 locus was replaced with the G437R mutant allele (tub1). Our results show that this mutation leads to alterations in tubulin isotype usage in cells, microtubule dynamics, and a spindle-positioning defect that is due to dysregulated dynein function. The dynein dysfunction phenotype is not a consequence of its mislocalization but is due to the reduced affinity of She1 for the mutant microtubules. Our data suggest that the presence of low copies of the mutant Tub1 α-tubulin protein in microtubules exerts allosteric, long-range effects on microtubule structure that lead to cooperative disruption of She1–microtubule binding yet protects cells against the severe morphological defects that arise in cells expressing only the compensatory Tub3 α-tubulin isotype. Although there is no clear She1 homologue in higher eukaryotes, we hypothesize that this mutation might interfere with dynein function in humans by disrupting the microtubule-binding behavior of a regulatory MAP, thus leading to neuronal physiological deficits and a consequent disruption of cerebral cortex development.

RESULTS

TUB1 leads to an enhancement in microtubule dynamics during G2/M

Glycine 436 of TUBA1A (α-tubulin) is conserved among α-tubulins from numerous organisms, including budding yeast (TUB1; overall 74.1% identity between human TUBA1A and yeast Tub1). Glycine 436 (Figure 1A, red sphere) is one of three highly conserved small, hydrophobic residues in α-tubulin that immediately precede the disordered C-terminal tails, or “E-hooks,” of α-tubulin (Figure 1B, red box). This region of α-tubulin partly constitutes the external surface of the microtubule to which MAPs and motor proteins bind (Supplemental Figure S1). Although some MAPs (i.e., Tau and Tpx2) bind proximal to G436, this residue does not appear to encompass the kinesin and dynein binding interfaces (see Supplemental Figure S1) (Nogales ; Lowe ; Alushin ). Modeling an arginine into position 436 of porcine α-tubulin (PDB 3J6G; using UCSF Chimera [ Pettersen ]) revealed that such a mutation may potentially disrupt the terminal helix of α-tubulin (note the steric clash between the modeled arginine and helix 11 in rotational isomers 1 and 4; Supplemental Figure S2). To assess the phenotypic consequences of this mutation, we engineered yeast strains to express Tub1G437R, in which the mutation was introduced at the native TUB1 locus.

Heterozygous diploid cells (TUB1/tub1) were sporulated, and the resulting haploid tub1 mutant cells were recovered at the expected frequency. The mutants exhibited no growth defects when cultured in nutrient-rich media (YPAD; see Figure 1D), indicating that the mutation does not compromise yeast cell viability. Using a chromosomally integrated RFP-tub1 (expressed in the presence of the untagged tub1 allele), we found that the mutant tubulin incorporates into spindle and cytoplasmic microtubules during all phases of the vegetative yeast cell cycle (G1, G2/M; Figure 1C).

Increased sensitivity of cells to the microtubule-depolymerizing drug benomyl is a common phenotype of strains with α- and β-tubulin mutations (Richards ). We assessed benomyl sensitivity of wild-type (TUB1) and tub1 cells by spotting a dilution series of each on solid media containing different concentrations of the drug (10 and 15 μg/ml; Figure 1D) and examining cell growth. In the presence of benomyl, cell growth was markedly impaired for tub1 cells compared with wild-type cells, indicating an enhanced sensitivity to the drug as a consequence of the mutant tubulin. These data suggest that the G437R mutant could be altering microtubule stability or dynamics.

To determine whether the G437R mutation affects microtubule dynamics, we measured dynamics parameters in cells by tracking the movement of microtubule plus ends with Bik1-GFP, the homologue of human CLIP-170 (see Figure 4A later in this article). Although we did not observe any notable differences in microtubule dynamics parameters between wild-type and tub1 cells in G1, we did note several differences during the G2/M phase of the cell cycle (Figure 2). In particular, we noted an increase in the rates of polymerization (1.4 µm/min in wild-type vs. 1.7 µm/min in mutant cells) and depolymerization for microtubules in tub1 cells (1.6 µm/min vs. 2.4 µm/min), phenotypes similar to those noted previously in yeast α-tubulin E-hook deletion mutants (Aiken ). We also observed a significant increase in the fraction of time the microtubules spent in their growth phase and a concomitant reduction in the relative fraction of time spent in pause in the mutant cells. This resulted in an overall increase in microtubule dynamicity (Toso ) (Figure 2), which may account for the enhanced sensitivity of the mutant cells to the depolymerizing agent, benomyl. Finally, although the mean microtubule length did not significantly differ between the two strains in G2/M (Supplemental Figure S3A), we noted that the mutant cells exhibited a larger fraction of long microtubules (38% of microtubules were ≥7 µm in tub1 cells vs. 10% in wild-type cells; Supplemental Figure S3B), many of which extended from one cell compartment to the other (also see below). Taken together, these data suggest that the G437R mutation alters microtubule function in a manner suggestive of E-hook disruption.

FIGURE 4:

Tub1G437R leads to enhanced spindle dynamics and a spindle mispositioning phenotype. (A) Representative inverse fluorescence time-lapse images of wild-type (TUB1) and tub1 mutant cells expressing Bik1-GFP. Note the increased spindle movements that are coincident with microtubule sliding events in the mutant cell (bottom; see 3′–6′ in the tub1 mutant example for a typical sliding event). Scale bar, 5 µm. (B) Displacement traces of the spindle noted over the 10 min acquisition period (each spot represents the position of the spindle centroid over time). (C, D) Plots depicting the average total displacement of the mitotic spindles in wild-type or mutant cells per minute of the acquisition period (C; n = 74 and 52 cells from three independent clones for TUB1 and tub1 strains, respectively) or the number of microtubule sliding events (in which a microtubule appears to slide along the cell cortex) per cell per minute (D; n = 57 and 41 cells from three independent clones for TUB1 and tub1 strains, respectively). Bars represent mean values with SE. (E) Fraction of microtubule sliding events (described above) that are followed by a microtubule catastrophe (n = 40 and 31 cells from three independent clones for TUB1 and tub1 strains, respectively). Bars represent weighted means with weighted SE of proportion. (F) Fraction of cells exhibiting microtubule sliding events in which a very long microtubule (extending from one cell compartment to the other) slides over the bud and mother cell before terminating (n = 57 and 46 cells from three independent clones for TUB1 and tub1 strains, respectively). Bars represent weighted means with weighted SE of proportion. (G) Plot depicting the fraction of cells with the indicated spindle location in control and mutant cells (from left to right, n = 233, 255, 141, 78, 82, and 130 cells from three independent clones). Bars represent weighted means with weighted SE of proportion. Statistical tests revealed P < 0.0001 for TUB1 versus tub1 (***), P = 0.7069 for TUB1 dyn1∆ versus tub1 and P = 0.0143 for TUB1 kar9∆ versus tub1 cells. For all panels, G2/M cells (determined based on morphological criteria, i.e., those with a bud diameter ≥75% of the mother cell) were selected for analysis. For panels C and D, P values were calculated using an unpaired Welch’s t test; for panels E–G, statistical significance was determined by calculating Z scores as previously described (Marzo ). For all plots, diamonds represent mean values obtained from each independent replicate experiment.

FIGURE 2.

tub1 cells exhibit altered microtubule dynamics during G2/M phase. Plots depicting the indicated microtubule dynamics parameters in the indicated phase of the cell cycle (as determined by cell and spindle morphology). Microtubule behavior was tracked over time using Bik1-GFP as a reporter (localizes prominently to the spindle, to various degrees along microtubules, and at microtubule plus ends). For each cell a single microtubule was used for dynamics measurements (n = 41 and 42 microtubules—from the same number of cells—from G1 TUB1 and tub1 cells, respectively, and n = 31 and 53 microtubules/cells from G2/M TUB1 and tub1, respectively). With the exception of the dynamicity plot (showing mean values with SDs), all plots depict all data points (scatter plots) along with mean and SDs (bars). P values were calculated using an unpaired Welch’s t test.

Reduced Tub1 G437R expression levels are compensated by Tub3 isotype

We next wondered whether the G437R mutation leads to alterations in α-tubulin levels in cells. To this end, we measured relative protein content via immunoblot (using two different antibodies that recognize α-tubulin: 4A1 and YL1/2), which revealed a significant reduction in total α-tubulin in the mutant cells (30.6–42.7% reduction, determined with 4A1 and YL1/2, respectively; Figure 3, A and B).

FIGURE 3:

Tub1G437R leads to changes in α-tubulin isotype usage in cells. (A) Representative immunoblots depicting relative α-tubulin expression in yeast strains with the indicated genotype. Lysates prepared from independent log phase cultures were separated by SDS–PAGE, transferred to PVDF, and then probed with either 4A1 or YL1/2 monoclonal antibodies, as indicated (n = 8 cell lysates prepared from independent cell cultures for 4A1 blot and n = 3 independent cell lysates for the YL1/2 blot). Before transfer, acrylamide gels were imaged for total protein (using Stain-Free technology; Bio-Rad) to normalize for potential differences in sample loading. (B) Plots depicting relative band intensities (mean ± SD) of α-tubulin measured from immunoblots. Diamonds represent values obtained from each independent replicate experiment. Note that α-tubulin levels in tub3∆ cells varied across the three replicates (from 0.56 to 0.92) for immunoblots processed with the YL1/2 antibody (in contrast to those processed with 4A1). (C, D) Representative fluorescence images (C; shown as a heatmap) and quantitation (D) depicting the relative intensity of mRuby2-Tub1 (wild type or mutant) or mRuby2-Tub3 in either spindle (left) or astral microtubules (right) in wild-type or mutant cells. Before imaging, cells were arrested with 200 mM hydroxyurea (HU) for 2.5 h (to enrich for cells with mitotic spindles) and then mounted on agarose pads containing HU for fluorescence microscopy (for data sets from left to right, n = 104, 106, 100, and 97 spindles and n = 108, 62, 98, and 90 astral microtubules from three biological replicates each, respectively; P values were calculated using an unpaired Welch’s t test). Diamonds represent values from independent biological replicates, and bars indicate mean ± SD. (E) Cartoon depicting the relative balance of Tub1-Tub2:Tub3-Tub2 in wild-type and mutant microtubules. (F) Representative image of colonies (grown on YPAD) from a tetrad dissection depicting the synthetic lethal interaction between tub1 and tub3∆. Two representative tetrads are shown. (G) Models of spindle microtubules built from EM tomographic volumes from a pre anaphase wild type (TUB1) and mutant cell, along with parameters determined. Blue and yellow lines depict microtubules emanating from SPB1 and SPB2, respectively, red spheres depict microtubule plus ends, and black disks depict SPBs (scale bar, 200 nm).

In addition to TUB1, budding yeast possess a second α-tubulin gene encoded by TUB3. Whereas TUB1 is reported to be the major α-tubulin isotype and is required for cell viability, cells tolerate deletion of TUB3, which possesses 91% identity and 95% similarity with TUB1 (Schatz ). Although previous studies estimated that Tub3 accounts for roughly ∼10–30% of the cell’s α-tubulin content (Bode ; Gartz Hanson ), we sought to assess this with our yeast strains and immunoblotting techniques. To this end, we assessed α-tubulin levels in tub3∆ mutants, in which all α-tubulin is encoded by TUB1. Interestingly, this revealed a 64.2% reduction in total α-tubulin content as a consequence of Tub3 deletion. We noted a similarly large reduction in total α-tubulin levels using the YL1/2 antibody (36.9%). This suggests that Tub3 comprises a larger proportion of tubulin in cells (∼36–63%) than previously reported.

We reasoned that the reduction in α-tubulin levels as a result of the G437R mutation would lead to two possible situations in mutant cells: 1) a reduction in the length or number of cytoplasmic and spindle microtubules, or 2) an increase in the levels of Tub3 incorporation into microtubules to compensate for the Tub1 reduction. Because we noted no reduction in astral microtubule number or length (Supplemental Figure S3) and a reduced overall microtubule mass (scenario 1 above) would likely lead to severe physiological consequences (e.g., chromosome segregation defects, reduced viability) that were not apparent by live cell imaging (see Figure 1C) or cell viability (see Figure 1D, “YPAD”), we focused on the latter possibility. To this end, we measured the fluorescence intensity of mRuby2-Tub1 (wild type or G437R) and mRuby2-Tub3 in both the mitotic spindle and individual astral microtubules in either wild-type or tub1 cells. We used identical imaging conditions (e.g., laser power, camera exposure) to quantitatively compare the relative incorporation of mRuby2-Tub1 and mRuby2-Tub3 into these microtubule structures. Consistent with our immunoblotting data, this revealed that Tub1 and Tub3 comprise roughly equal proportions of microtubules in wild-type (TUB1) cells (Figure 3, C and D); however, these values differed significantly in tub1 cells, in which Tub1G437R incorporation into microtubules was reduced by 40 and 61% in astral and spindle microtubules, respectively, and Tub3 levels were increased by 55 and 58% in astral and spindle microtubules, respectively. Thus, the reduction of Tub1G437R incorporation into cellular microtubules is entirely offset by a compensatory incorporation of Tub3 (Figure 3E), leading to a situation in which the overall microtubule mass likely remains unchanged.

Given the apparent compensation of Tub3 for tub1 in mutant cell microtubules, we wondered whether cells could tolerate expressing only Tub1G437R in the absence of Tub3. To this end, we generated heterozygous TUB1/tub1/tub3∆ diploid cells, sporulated them, and assessed the viability of the recovered single- and double-mutant progeny. Although the single mutants exhibited normal colony morphology, none of the double mutants was viable (12 out of 12 expected double mutants from 24 tetrads were inviable), revealing that expression of only Tub1G437R leads to cell death (Figure 3F). Although the reason for the inviability of the double mutants is unclear, it suggests that either microtubules cannot be assembled from only the mutant α-tubulin protein or microtubules assembled from only the mutant α-tubulin protein do not support proper cellular function.

To determine whether mitotic spindles assembled in tub1 cells exhibit normal morphological characteristics (e.g., numbers and arrangements of microtubules), we compared the spindle organization between wild-type and mutant cells using electron tomography. Asynchronous cell cultures were collected and subjected to high-pressure freezing. Serial sections of cells with mitotic spindles were imaged by electron microscopy, and the microtubules were modeled from tomographic volumes, as previously described (Winey ; O’Toole , 2002). This revealed that spindles in the mutant cells were morphologically indistinct from those in wild-type cells (Figure 3G and Supplemental Videos S1 and S2). Specifically, the number of microtubules per mitotic spindle in the mutant cells (34 ± 1.7, mean ± SD, for tub1) was similar to those values observed in our wild-type cells (40.5 ± 4.9, mean ± SD, for TUB1) and to those measured previously (between 26 and 62 microtubules per spindle [ Winey ; Nazarova ; Fees ; Leary ]). To confirm this result, we compared the spindle-localized fluorescence intensity values for GFP-Bim1 (homologue of human EB1) in wild-type and tub1 cells, a protein that binds to microtubule plus ends and localizes prominently to the spindle midzone (Schwartz ; Khmelinskii ; Gardner ; Zimniak ). This revealed no significant difference in the intensity values for Bim1 spindle localization between wild-type and tub1 cells (Supplemental Figure S4, A and B). Thus, although our tomogram data set was small, our data suggest that neither the mutation nor the increased incorporation of Tub3 into the spindle microtubules leads to alterations in spindle microtubule number or defects in spindle assembly. It is interesting to note that the total number and length of microtubules appear to be unchanged in the mutant cells despite the significant reduction in total α-tubulin levels. This suggests that the levels of α-tubulin in tub1 cells (and likely tub3∆ as well) remain above the critical concentration required for microtubule assembly. This is consistent with a previous study indicating that cells with α-tubulin levels reduced by as much as 50% are phenotypically normal (Katz ).

Movie S1

Serial tomographic slices and model of microtubules from a wild-type pre-anaphase spindle. The tomographic volume (from TUB1 cell 2, as indicated in Figure 3G) was built from three 250 nm sections in which the nuclear envelope, SPBs, and spindle microtubules are all apparent. Blue and yellow lines depict microtubules emanating from each of the two SPBs, red spheres depict microtubule plus ends, and black disks depict SPBs. Scale bar = 250 nm.

Movie S2

Serial tomographic slices and model of microtubules from a tub1G437R pre-anaphase spindle. The tomographic volume (from tub1G437R cell 2, as indicated in Figure 3G) was built from three 250 nm sections in which the nuclear envelope, SPBs, and spindle microtubules are all apparent. Blue and yellow lines depict microtubules emanating from each of the two SPBs, red spheres depict microtubule plus ends, and black disks depict SPBs. Scale bar = 250 nm.

The G437R mutation leads to increased spindle dynamics and impaired spindle positioning

Because the G437R mutation specifically affects microtubule dynamics during G2/M, during which astral microtubules facilitate mitotic spindle movements (by the Kar9/actomyosin and dynein pathways), we sought to assess the consequence of the mutation on these movements using Bik1-GFP as a fluorescent reporter (Figure 4A). In wild-type cells, spindles sample a relatively small area near the bud neck in the mother cell, and most of them are oriented along the mother–bud axis (Supplemental Figure S4, B and C). Although the majority of spindles in tub1 cells were also oriented along the mother–bud axis (Supplemental Figure S4C), they exhibited highly dynamic behavior; specifically, we observed numerous instances of the spindle oscillating back and forth between the mother and daughter cell compartments (Figure 4, A and B, bottom). To quantitate this phenomenon, we measured the total distance over which the mitotic spindle moves per minute within each cell. Compared with wild-type cells (TUB1), spindles in tub1 cells move a significantly longer distance (0.7 vs. 1.2 µm cell-1 min-1; Figure 4C). These observations indicate that excessive forces originating from the mother and bud cortex are exerted upon the mitotic spindle in tub1 cells. We also noted that the spindle movements in tub1 cells occur coincidently with microtubule “sliding” events, during which the plus end of the astral microtubule contacts the cell cortex and then curls along it, all the while maintaining lateral contact (see Figures 4A, bottom, and 3′–6′; Supplemental Video S3). Quantitation of these movements—which are characteristic of dynein-mediated spindle movement events (Adames and Cooper, 2000)—revealed an approximately twofold increase in their frequency in tub1 cells with respect to wild-type cells (Figure 4D).

Movie S3

Representative movies of TUB1 and tub1G437R cells expressing Bik1-GFP. Movies from TUB1 (left) and tub1G437R (right) cells expressing Bik1-GFP are shown. Note the presence of a long cytoplasmic microtubule in the tub1G437R cell extending from the top compartment to the bottom while undergoing an apparent dynein-mediated sliding event. See Figure 4F for quantitation of the frequency with which these events were observed.

A recent study found that dynein-mediated microtubule sliding events are often followed by a microtubule catastrophe (also mediated by dynein), which plays a role in attenuating the spindle movement events (Estrem ). We noted that these particular microtubule catastrophe events (i.e., those following sliding events) are greatly reduced in tub1 cells (29% of sliding events are followed by catastrophe in tub1 cells vs. 85% in wild-type cells; Figure 4E), suggesting that the G437R mutation reduces dynein’s ability to promote a catastrophe. Also consistent with these data, a larger fraction of mutant cells appeared to exhibit events in which very long microtubules that extended from one compartment to the other (i.e., mother to bud or vice versa) underwent characteristic dynein-mediated sliding between the two cellular compartments (Figure 4F; also see Supplemental Video S3).

The main function of cytoplasmic microtubules in vegetative yeast cells is to orient the mitotic spindle along the mother–bud axis (presumably by the Kar9/actomyosin pathway) and localize it proximally to the bud neck (by the dynein pathway) such that at the time of anaphase onset, the chromosomes are divided equally between the mother and daughter cells (Li ; Carminati and Stearns, 1997; Yin ; Hwang ; Liakopoulos ). Although we found that orientation of the spindle along the mother–bud axis was not compromised in tub1 cells (Supplemental Figure S4; note that our data suggest that both dynein and Kar9/actomyosin pathways affect this phenomenon), we did note that the spindle was more frequently localized to the apical regions of the mother or daughter cells in the tub1 strain (26% of tub1 cells vs. 9% of wild-type cells; Figure 4G). Analysis of cells deleted for either the dynein heavy chain (DYN1) or KAR9 with or without tub1 revealed that the tubulin mutation increases the frequency of spindle-position defects in kar9∆ but not dyn1∆ cells, suggesting that G437R disrupts the function of the dynein but not the Kar9/actomyosin pathway (Figure 4G). Taken together, these observations suggest that the G437R mutation leads to increased dynein-mediated spindle movements and yet reduced dynein-mediated microtubule catastrophe events (following sliding events), which ultimately leads to a spindle-mispositioning phenotype.

Enhanced spindle dynamics in tub1 mutant cells are dynein dependent

As noted above, the dynein pathway mediates microtubule sliding events that result in translocation of the mitotic spindle throughout the cell. Given our observations noted above, we sought to determine whether the tub1 mutant phenotypes are a consequence of hyperactive dynein. Consistent with the notion that dynein is responsible for the observed spindle behavior in tub1 cells, the increased spindle displacement phenotype in tub1 cells was eliminated by deletion of DYN1 but not by deletion of KIP3, a kinesin that has been implicated in regulating microtubule length and spindle movements (Figure 5, A and B) (Gupta ; Fukuda ).

FIGURE 5:

Enhanced spindle movement phenotype in tub1 cells is dynein dependent. (A) Plot depicting the average total displacement of the mitotic spindle in cells with the indicated genotype per minute of the acquisition period (for strains from left to right, n = 63, 24, 35, 35, 55, 35, 45, and 45 cells from two or three independent clones, respectively; P values were calculated using an unpaired Welch’s t test). (B) Representative displacement traces of the spindle noted over the 10 min acquisition duration for the indicated strains. (C) Representative fluorescence images of cells expressing Dyn1-3GFP and RFP-Tub1 (wild type or mutant) in either wild-type or mutant cells, as indicated (white arrowheads indicate cortical foci, the white arrows indicate plus end foci, and the blue arrowheads indicate SPB foci). (D, E) Fluorescence intensity measurements of (D) and fraction of cells with (E) Dyn1-3GFP foci at the indicated subcellular localization in TUB1 and tub1 strains (for D, data sets from left to right, n  = 56, 52, 58, 49, 60, and 36 cells from two independent replicates; values from independent replicates are shown in two shades of green and magenta; for E, n = 248 and 232 cells for wild-type and mutant cells, respectively, from two independent replicates). For panel A, P values were calculated using an unpaired Welch’s t test. Diamonds represent mean values obtained from each independent replicate experiment.

We next asked whether the increased dynein activity is due to enhanced targeting of dynein to microtubule plus ends or the cell cortex, which can be causative of increased cellular dynein activity (Markus ). To this end, we imaged Dyn1-3GFP in cells also expressing RFP-Tub1 (or RFP-Tub1G437R) in wild-type or tub1 cells (Figure 5, C–E). We found no significant difference in either the frequency of Dyn1-3GFP targeting or the fluorescence intensity values for Dyn1-3GFP at microtubule plus ends, SPBs, or the cell cortex (Figure 5, D and E). Thus, the increased dynein activity in tub1 cells is likely not a consequence of increased localization to any of these sites.

G437R tubulin and microtubules exhibit reduced interaction with the dynein regulator She1

We wondered whether the apparent increase in dynein activity in tub1 cells could be a consequence of reduced microtubule binding by the MAP She1, a dynein inhibitor (Woodruff ; Markus , 2012). To determine whether this might be the case, we first employed our spindle dynamics assay, which revealed that deletion of She1 in otherwise wild-type cells leads to an increase in spindle displacement (Figure 5A). Interestingly, the extent of the increase was similar to that noted in tub1 cells and was only mildly increased further by the addition of the tub1 allele. Thus, the tub1-dependent increase in spindle displacement is phenocopied by and partially epistatic to SHE1 deletion.

We previously found that She1-mediated inhibition of dynein activity requires its microtubule-binding activity (Ecklund ). To determine whether G437R affects the She1-–microtubule interaction, we employed several approaches. First, we tested the effect of G437R on the interaction between She1 and tubulin. A She1-Gal4 activation domain (AD) fusion was tested for a two-hybrid interaction with either Tub1 or Tub1G437R, the latter of which was fused to the LexA DNA-binding domain (LexADBD). Bim1, which is known to interact with α-tubulin in a two-hybrid assay (Schwartz ; Krogan ), was used as positive control, as was the kinesin Kip3. As expected, Bim1, Kip3, and She1 all exhibited a two-hybrid interaction with the Tub1 bait (Figure 6A; positive interactions are apparent by growth on media lacking histidine, “–HIS”). Interestingly, the interaction between She1 and Tub1—but not between Tub1 and either Bim1 or Kip3—was reduced to background levels by the G437R mutation (Figure 6A).

FIGURE 6:

She1–tubulin and microtubule binding is reduced by the G437R mutation. (A) Two-hybrid assay illustrating the relative degree of interaction between tubulin (wild type or mutant) and either the microtubule end–binding protein Bim1 (homologue of human EB1), the kinesin-8 Kip3, or the dynein inhibitor She1. Serial dilutions of cells were spotted on minimal sold media with (top) or without (bottom) histidine. Growth on histidine-deficient media is indicative of an interaction between bait and prey proteins. (B) Coomassie-stained acrylamide gel illustrating a representative pull down of cow brain tubulin by NiNTA-immobilized 6His-She1Cter. (C) Representative anti-tubulin immunoblot and quantitation of an experiment in which a peptide corresponding to the tubulin C-terminal tail (wild type or mutant) was used to compete bound tubulin off of a NiNTA-immobilized 6His-She1Cter (n = 2 independent replicates). (D) Representative fluorescence images (left, along with heatmap depicting relative intensity of She1-HaloTag660, right) depicting purified She1 binding to microtubules polymerized using tubulin from yeast cells the with indicated genotype (arrowheads depict some of the microtubule seeds to which She1 appears to bind to a lower extent). (E) Plots depicting fluorescence intensity values (mean ± SD) for microtubule-bound She1 (n = 60 microtubules for each condition from two independent replicates; all values from independent replicates are shown in two shades of green and magenta). The P value was calculated using a Mann–Whitney test.

Like many MAPs, the interaction between She1 and microtubules requires the disordered C-terminal tails of tubulin (Markus ; Ecklund ). Thus, to further confirm the importance of G437 in the She1-tubulin interaction, we performed a pull-down assay in which this interaction was competitively inhibited by the addition of a peptide encompassing the C-terminus of Tub1 (amino acids 415–447; both She1 and tubulin were used at 5 µg/ml or below, well below the critical concentration required for microtubule assembly). To this end, a 6His-She1 C-terminal fragment (She1Cterm; residues 194–338; which is sufficient for microtubule binding [ Zhu ]) was incubated with tubulin (see Figure 6B for specificity of tubulin–She1Cterm interaction) in the absence or presence of a peptide corresponding to the C-terminus of either wild-type or G437R tubulin. The relative extent to which the NiNTA bead–immobilized 6His-She1Cterm pulled down tubulin was subsequently assessed by SDS–PAGE and immunoblot (using an antibody against α-tubulin). This revealed that the She1Cterm–tubulin interaction was strongly competed by the wild-type peptide, but much less so by the same peptide with the G437R mutation (Figure 6C).

In an attempt to directly measure the ability of She1 to bind to microtubules composed of Tub1G437R and Tub2 (the latter encoding β-tubulin), we purified wild-type and mutant tubulin heterodimers from budding yeast using previously established methodologies (Gupta ; Johnson ) (in which Tub2 is fused to a C-terminal 6His tag; Supplemental Figure S5A). We confirmed the presence of Tub1, Tub2 (both of which were overexpressed), and low levels of copurifying Tub3 (which was not overexpressed) in both protein preparations by liquid chromatography–coupled tandem mass spectrometry (LC/MS) (Supplemental Figure S5B). These data also revealed that similar amounts of wild-type and mutant Tub1 copurified with Tub2, indicating that each is equally competent for heterodimerizing with Tub2. However, although we were able to reconstitute yeast microtubules using purified wild-type Tub1/Tub2 heterodimers (Supplemental Figure S5C), we were unable to do so using purified Tub1G437R/Tub2. The inability of the mutant protein to polymerize suggests that Tub1G437R is not sufficient to assemble microtubules in the absence of Tub3 (as suggested by the synthetic lethality of tub1 and tub3∆) and the mutation functionally compromises tubulin’s polymerization activity.

We thus employed an alternate strategy to assemble microtubules from either wild-type or mutant tubulin (Bergman ). Specifically, we prepared concentrated cell lysates from either wild-type or tub1 cells (both of which possessed wild-type TUB3) and incubated them in microscope chambers in which preassembled microtubule seeds were affixed. This results in the polymerization of microtubules (due to the high concentration of tubulin within the extracts; see Supplemental Figure S5D, for example) that we then incubated with recombinant, fluorescent She1 (She1-HaloTag660) purified from budding yeast. This revealed that She1 indeed binds to wild-type microtubules to a greater extent than those prepared from tub1 cells (Figure 6, D and E).

Finally, we measured the extent to which She1 localizes to microtubules in cells by comparing the relative recruitment of full-length She1 to spindle microtubules (where She1 fluorescence is most prominent) in either wild-type or tub1 cells. Consistent with the two-hybrid and in vitro data described above, we found that spindle-localized She1 fluorescence was 55.7% lower in tub1 cells than in wild-type cells (Figure 7, A and B).

FIGURE 7:

In vivo microtubule binding by She1 is reduced by the G437R mutation. (A–D) Representative fluorescence images (shown as a heatmap; A and C) and quantitation (B and D) depicting the relative degree of spindle-localized GFP11x7-She1 in wild-type or mutant cells, as indicated. Before imaging, cells were arrested with 200 mM hydroxyurea (HU) for 2.5 h (to enrich for cells with mitotic spindles) and then mounted on agarose pads containing HU for fluorescence microscopy (n = 52 cells for each condition for B and n = 60 and 53 cells for TUB1 TUB3 and TUB3-only cells, respectively, for C, all from two independent replicates; all values from independent replicates are shown in two shades of green, magenta, or orange, along with mean ± SD). P values were calculated using an unpaired Welch’s t test. (E) Representative fluorescence images (left, along with heatmap depicting relative intensity of She1-HaloTag660, right) depicting purified She1-HaloTag660 binding to microtubules polymerized using tubulin from yeast cells with the indicated genotype. (F) Plots depicting fluorescence intensity values (mean ± SD) for microtubule-bound She1 (n = 60 microtubules for each condition from two independent replicates; all values from independent replicates are shown in two shades of blue and orange). The P value was calculated using a Mann–Whitney test. (G) Model of spindle microtubules built from EM tomographic volumes from a preanaphase TUB3-only cell, along with the parameters determined. Green and magenta lines depict microtubules emanating from SPB1 and SPB2, respectively, and blue disks depict SPBs (“P-A” and “M-A” indicate cells that are in preanaphase and midanaphase, respectively).

As noted above, spindle microtubules in tub1 cells are composed of a greater proportion of Tub3 than those in wild-type cells (see Figure 3E). Thus, the reduced microtubule-binding (Figure 6E) and She1-spindle localization (Figure 7B) noted above could potentially be a consequence of She1 binding to Tub3-containing microtubules to a lesser extent. To determine whether this might be the case, we sought to engineer yeast cells expressing only Tub3. Although the expression of one copy of TUB3 in the absence of TUB1 is indeed lethal, previous studies reported that this lethality could be rescued by integration of a second copy of TUB3 into the genome (Schatz ; Bode ). To this end, we integrated a plasmid expressing Tub3 (under control of the strong constitutive promoter TEF1p) into the genome of TUB1/tub1∆ heterozygote diploid cells, sporulated them, and assessed the viability of the recovered progeny. As expected, no single tub1∆ mutants were recovered, while all tub1∆ TEF1p:TUB3 double mutants were indeed viable (Supplemental Figure S6A), although with colony sizes significantly smaller than those in wild type (Supplemental Figure S6B). Interestingly, we noted that TUB1 TEF1p:TUB3 cells were less healthy than tub1∆ TEF1p:TUB3 double mutants, as was apparent by the reduced colony size of the former (Supplemental Figure S6B). Although the growth defects for these cells may be a consequence of the excessive α-tubulin levels, previous studies have found that overexpressing Tub1 does not compromise cell viability (in contrast to Tub2) (Burke ).

Using the tub1∆ TEF1p:TUB3 (“TUB3-only”) cells, we found that the extent of spindle-localized She1 was not reduced on microtubules composed of only Tub3-Tub2 heterodimers. In fact, the mean intensity of spindle-localized She1 was 61.7% greater in TUB3-only cells. To confirm these results and to more carefully determine the relative ability of She1 to associate with Tub1- versus Tub3-containing microtubules, we assessed the extent to which She1 binds to microtubules generated from concentrated lysates prepared from either TUB1-only (TUB1 tub3∆) or TUB3-only (TEF1p:TUB3 tub1∆) cells. This revealed that She1 exhibits a slight preference for microtubules composed of Tub3-Tub2 versus Tub1-Tub2 heterodimers (Figure 7, E and F). Taken together, these findings indicate that She1 indeed binds to Tub1G437R-containing microtubules to a lesser extent, thus accounting for the hyperactive dynein phenotype in these cells.

Mitotic spindles in TUB3-only cells are comprised of more microtubules than those in wild-type cells and are misoriented

As noted above, our immunoblot and fluorescence data suggest that Tub3-Tub2 heterodimers comprise a larger fraction of cellular microtubules than previous results have suggested. In light of this, we wondered what—if any—consequences would result from eliminating all the Tub1 α-tubulin isotype from microtubules that comprise the mitotic spindle. To this end, we modeled spindle microtubules from tomographic volumes generated from our TEF1p:TUB3 tub1∆ (“TUB3-only”) mutant cells. This analysis revealed one striking difference between spindles from TUB3-only cells and those from wild-type cells: three of the four models from preanaphase cells (“P-A”) revealed a much larger number of microtubules emanating from each SPB (64, 74, and 76 total microtubules per mitotic spindle, respectively; Figure 8A and Supplemental Videos S4 and S5), while the fourth possessed a number much closer to wild-type values (38 total). Measurements of SPB diameters revealed that those cells with larger numbers of microtubules also possessed larger SPBs (Figure 8A). These findings suggest that the increased spindle intensity values for She1 in TUB3-only cells may largely be a consequence of the increased microtubule number, especially in light of the small increase in She1-binding affinity for Tub3-only microtubules that we observed in vitro.

FIGURE 8:

TUB3-only cells nucleate more spindle microtubules from enlarged SPBs. (A) Model of spindle microtubules built from EM tomographic volumes from a preanaphase TEF1p:TUB3 tub1∆ (“TUB3-only”) cell, along with parameters determined from five models. Blue and yellow lines depict microtubules emanating from SPB1 and SPB2, respectively, red spheres depict microtubule plus ends, and black disks depict SPBs (scale bar, 200 nm; “P-A” and “M-A” indicate cells that are in preanaphase and midanaphase, respectively). (B) Plot depicting time interval between SPB duplication (a marker for the initiation of spindle assembly) and anaphase onset (n = 197 and 196 cells for wild-type and TUB3-only cells, respectively, from two independent replicates each). Cells were grown in a microfluidics cassette (CellAsic ONIX; see Materials and Methods) and imaged over the course of several cell cycles. The P value was calculated using a Mann–Whitney test. (C) Representative images and cartoon schematic depicting spindle angles measured and plotted in panel D (dashed lines indicate mother–bud axis in select cells; note that drawings indicate mean spindle angle for wild-type and mutant cells). Before imaging, cells were arrested with 200 mM HU for 2.5 h (to enrich for cells with mitotic spindles) and then mounted on agarose pads containing HU for fluorescence microscopy. (D) Rose plots depicting the angles of preanaphase spindles with respect to the mother–bud axis (n = 186 and 165 cells from two independent replicates from TUB1 TUB3 and TUB3-only cells, respectively). Dashed lines indicate mean values for independent replicates (32.6° and 30.6° for TUB1 TUB3 and 51.0° and 50.8° for TUB3-only). The P value was calculated using a Mann–Whitney test. (E) Representative images of colonies (grown on YPAD) from a tetrad dissection from mating TUB3-only (tub1∆ TEF1p:TUB3) cells with either kar9∆ (left) or dyn1∆ (right) mutants depicting the relative size of TUB3-only kar9∆ (orange boxes), TUB3-only dyn1∆ (light blue boxes) colonies, and TUB3-only (purple boxes) colonies. Two representative tetrads are shown from each. (F) Plot depicting relative area of colonies with the indicated genotype. Note that the combination of TUB3-only with dyn1∆ results in smaller colony sizes than either TUB3-only kar9∆ or TUB3-only alone (from left to right, n = 30, 9, and 19 mutants obtained from 47 and 63 tetrads from each dissection, respectively). P values were calculated using an unpaired Welch’s t test.

Movie S4

Serial tomographic slices and model of microtubules from a TUB3-only pre-anaphase spindle. The tomographic volume (from TEF1p:TUB3 tub1Δ cell 3, as indicated in Figure 8A) was built from four 250 nm sections in which the nuclear envelope, SPBs, and spindle microtubules are all apparent. Blue and yellow lines depict microtubules emanating from each of the two SPBs, red spheres depict microtubule plus ends, and black disks depict SPBs. Note the spindle is misoriented with respect to the mother-bud axis (which transverses the image from bottom-left to top-right; approximately 90° with respect to this axis). Scale bar = 250 nm.

Movie S5

Serial tomographic slices and model of microtubules from a TUB3-only pre-anaphase spindle. The tomographic volume (from TEF1p:TUB3 tub1Δ cell 2, as indicated in Figure 8A) was built from three 250 nm sections in which the nuclear envelope, SPBs, and spindle microtubules are all apparent. Blue and yellow lines depict microtubules emanating from each of the two SPBs, red spheres depict microtubule plus ends, and black disks depict SPBs. Scale bar = 250 nm.

We next assessed whether spindles from TUB3-only cells can assemble a “core bundle” of microtubules—antiparallel microtubules emanating from opposite spindle poles that laterally associate and likely participate in spindle elongation during anaphase (Winey ). This revealed that a core bundle was indeed present in longer spindles (e.g., in cell numbers 1, 3, and 4), including one spindle that was in the midst of anaphase (cell number 5). These observations suggest that microtubule cross-linking proteins (e.g., Ase1, Kip1, Cin8) are capable of binding to microtubules composed entirely of Tub3-Tub2 heterodimers.

Much like our TUB3-only cells, a previous study found that spindles from mitotically arrested cells (using a conditional mutant of the checkpoint protein Cdc20) possess greater numbers of microtubules emanating from each SPB (mean of 81 microtubules per spindle) (O’Toole ). Thus, we wondered whether the increased microtubule number in the TUB3-only cells is a consequence of a mitotic arrest phenotype. To determine whether this may be the case, we quantitated mitotic duration by measuring the interval of time between SPB duplication (a marker for the start of spindle assembly) and onset of anaphase (as determined by the separation of the SPBs from one another). This revealed a 26% delay between the initiation of spindle assembly and anaphase onset (Figure 8B), indicating that a mitotic arrest may possibly account for the expansion of the SPB noted by our EM analysis. However, compared with the extensive arrest employed with the cdc20-1 mutant cells described above (grown for 4 h at the restrictive temperature) (O’Toole ), it is unclear whether this short delay (39.9 vs. 50.3 min) is the basis for the expanded SPB and enhanced microtubule number in these cells.

In addition to increased microtubule numbers in TUB3-only cells, we also noted the presence of preanaphase spindles in these cells that were not oriented along the mother–bud axis (e.g., see Supplemental Video S4). We quantitated this phenomenon by measuring the angle of the mitotic spindle with respect to the mother–bud axis (Figure 8C), which revealed that TUB3-only cells indeed exhibit a spindle orientation defect similar to that of cells deleted of either KAR9 or DYN1 (see Supplemental Figure S4, B and C). In contrast, we noted that spindles in the TUB3-only cells were not mislocalized to the apical regions of the mother or daughter cells (Supplemental Figure S6C; compare to Figure 4G), suggesting that dynein function is not compromised in cells containing microtubules exclusively composed of Tub3-Tub2 heterodimers. These data also confirm that the increased incorporation of Tub3 into microtubules in tub1 cells is not responsible for the spindle-positioning defect in these cells, and in fact the presence of Tub1G437R appears to protect cells against defects in spindle orientation.

Finally, in an attempt to determine whether TUB3-only cells are compromised in dynein or Kar9 function, we mated them with either dyn1∆ or kar9∆ cells and assessed the viability of the resulting haploid TUB3-only kar9∆ or TUB3-only dyn1∆ mutant cells. It is well established that budding yeast rely on dynein or Kar9 pathway function for viability and that defects in either pathway result in synthetic growth defects when combined with mutations in the other (Miller and Rose, 1998). Although all triple mutants (tub1∆ TEF1p:TUB3 dyn1∆ and tub1∆ TEF1p:TUB3 kar9∆) were viable, we noted that their respective colony sizes were smaller than those with wild-type KAR9 and DYN1 (Figure 8E). Colony area measurements revealed that TUB3-only dyn1∆ cells exhibited more-severe growth defects than TUB3-only kar9∆ cells (Figure 8F). Although additional study is required to definitively determine which pathway is compromised in TUB3-only cells, these data suggest that KAR9 pathway function is more significantly impacted than dynein pathway function. These data suggest that Tub1 and Tub3 have unique, noncomplementary functions that are each required for microtubule-dependent functions. Although the mechanism underlying disruption of the Kar9 pathway in TUB3-only cells is unclear, it may be a consequence of disrupted microtubule binding by effectors of this pathway (e.g., Bim1, Kip3).

DISCUSSION

In summary, we have used budding yeast to characterize the consequences of mutating G437 in α-tubulin (equivalent to G436 in TUBA1A), which was likely causative of MCD in at least two human patients (Bahi-Buisson ; Hebebrand ). Our results indicate that the mutant protein retains the ability to assemble into microtubules; however, we find that it is incorporated into microtubules to a lesser extent than wild-type α-tubulin due to either protein degradation or structural and/or functional defects associated with the mutation. Our inability to generate microtubules in vitro using only purified Tub1G437R and Tub2 suggests that the latter is more likely. The reduced incorporation of the mutant tubulin into microtubules appears to be compensated by a corresponding increase in Tub3 incorporation in the tub1 mutant cell microtubules. Although the mutant cells are capable of assembling mitotic spindles that are morphologically indistinct from those of wild-type cells, they exhibit dramatic alterations in their spindle positioning function. Using a combination of in vitro and in vivo methods, we attribute these changes to hyperactive dynein function that is likely a direct consequence of reduced microtubule binding by the dynein inhibitor She1. Moreover, the disrupted She1–microtubule binding in these cells is a direct consequence of microtubule-incorporated Tub1G437R and not increased Tub3 levels. These data are consistent with our recent findings that She1 must bind to microtubules to inhibit dynein motility (Ecklund ).

We find that Tub1G437R-Tub2 heterodimers occupy only a small fraction of microtubules in cells (17–22%), with Tub3-Tub2 comprising the majority. Despite this, the mutant appears to reduce the She1–microtubule interaction by 56.1% in cells and 33.6% in vitro, suggesting that Tub1G437R-Tub2 heterodimers are reducing the ability of neighboring Tub3-Tub2 heterodimers to bind She1. Although a cooperative microtubule-binding mechanism by She1 may potentially account for this, no such cooperativity has been observed (Markus ). Thus, in addition to directly affecting individual MAP-binding sites (i.e., in direct proximity of G437), these data suggest that the mutation exerts allosteric effects on the overall surface architecture of the microtubule. Previous evidence indicates that allostery can indeed be propagated along the lattice. For example, binding of kinesin-1 at its intradimer binding site on the microtubule has been shown to allosterically affect microtubule structure, which in turn promotes the binding of additional kinesins to neighboring binding sites (Shima ). This model can account for how tubulin mutants that retain polymerization activity can “poison the well” and exert dominant negative effects on cellular microtubule function, whereas those heterozygous tubulin mutations that lead to protein misfolding or polymerization incompetence are more likely to be innocuous.

It is interesting to note that the effects of G437R on microtubule dynamics were significant only during the G2/M phase of the cell cycle, at which point the growth and shrinkage rates and the overall dynamicity increase significantly as a consequence of the mutation. Although the reasons for the cell cycle–dependent differences are unclear, they may be due to an inability (or an increased ability) of a G2/M-specific factor to bind to and affect microtubule dynamics (either from the plus end or along the lattice). Given the importance of the C-terminal tail in microtubule binding by numerous factors and the proximity of G437 to the C-terminal tail of α-tubulin, the possibility that this mutation is in fact impacting the structure/function of this region is a likely scenario. Although it is unclear whether She1 affects microtubule dynamics, its reduced binding affinity for the mutant microtubules raises the possibility that the altered dynamics are a direct consequence of disrupted She1–microtubule binding or an indirect cause of She1’s inability to modulate dynein or dynein–dynactin (see below). Of note, a previous study observed an ∼17% increase in the rate of microtubule polymerization in mutant α-tubulin–expressing yeast that was eliminated upon deletion of Tub3 (Gartz Hanson ), suggesting that increased incorporation of Tub3 into microtubules leads to faster polymerization rates. This observation suggests that the increased proportion of Tub3 in the microtubules in tub1 cells may be at least partially responsible for the altered dynamicity observed here (16% increase in polymerization rate).

Also of interest is the apparent change in microtubule dynamics that we observed specifically during and subsequent to dynein-mediated microtubule sliding events. This decreased frequency of catastrophe events results in a greater proportion of long microtubules in the tub1 strain, which may also partly account for the increase in dynein activity. It has been shown that increased microtubule lengths directly correlate with enhanced dynein activity in cells (Estrem ). Although the role of She1 in affecting microtubule dynamics is not clear, it is possible that dynein-mediated depolymerizing activity—as has been noted in vivo (Estrem )—requires microtubule-bound She1. In particular, Estrem recently showed that microtubules undergo a catastrophe event coincident with a dynein-mediated sliding event. They proposed that offloading of dynein–dynactin (the latter of which is a critical regulator of dynein activity) from microtubule plus ends to the cell cortex shifts the balance such that dynactin—which presumably stabilizes microtubules—is depleted from plus ends, while sufficient levels of dynein—which destabilizes microtubules—remain plus end associated. In addition, previous studies found that She1 plays a role in precluding dynein–dynactin interaction at microtubule plus ends (Woodruff ; Markus ). Thus, either dynein-mediated microtubule destabilization or dynactin-mediated microtubule stabilization might be enhanced or reduced, respectively, by microtubule-bound She1. Although it is unclear whether She1 needs to bind microtubules to affect dynein–dynactin interaction, it is possible that the Tub1G437R-mediated reduction in She1–microtubule binding might also enhance dynein-mediated recruitment of dynactin to plus ends, which would presumably provide a microtubule stabilization effect (due to the increased presence of dynactin). These models are not mutually exclusive and may in fact both be acting to affect microtubule length during dynein-mediated spindle movement events.

Our findings also challenge the notion that Tub3 is a minor α-tubulin isotype in yeast. Rather, our immunoblotting and live cell imaging data indicate that Tub3 comprises approximately 50% of the free and polymerized α-tubulin pool. Despite this, yeast cells can tolerate expressing only Tub1 but are inviable when only one copy of Tub3 is expressed (Schatz ). Although overexpressing Tub3 can compensate for this inviability (Bode )—with significant consequences to cell health—this leads to cells with larger SPBs, greater numbers of spindle microtubules, and defects in spindle orientation. The reason for these phenotypes is unclear; however, perhaps the increase in spindle microtubule numbers is a compensatory mechanism exercised by TUB3-only cells to perform basic microtubule-dependent functions. For instance, perhaps Tub3-only microtubules bind to kinetochore-associated microtubule-binding proteins (e.g., the Ndc80 or Dam1 complexes) with lower affinity and a greater number of microtubules are required to overcome this deficit and ensure that kinetochores are captured with appropriate timing. Given the smaller C-terminal E-hook on Tub3 (only two glutamates in Tub3 vs. 4 in Tub1; see Figure 1) and the importance of this region for Ndc80 and Dam1 complex–microtubule binding (Westermann ; Ciferri ), this may be the case. This notion is supported by the somewhat prolonged interval between the initiation of spindle assembly and anaphase onset in TUB3-only cells. It is also interesting to note that the mutant Tub1G437R reduces the defects apparent in TUB3-only cells (compare Figure 3G to Figure 8A, and Supplemental Figure S4C to Figure 8D), indicating that even low levels of the mutant protein support microtubule functions not provided by Tub3.

Given the consequences for apparent brain development in two patients with missense mutations at TUBA1AG436 (pachygyria and severe microcephaly associated with postural delay and poor communication abilities in one patient, and abnormal cortical gyration among other phenotypes in a second [ Bahi-Buisson ; Hebebrand ]) and the strong link between mutations in dynein activity and motor neuron diseases and developmental brain disorders (Vissers ; Willemsen ; Bahi-Buisson ; Laquerriere ; Marzo ), our data linking disrupted dynein activity with this mutation are not entirely surprising. For example, dynein activity is critical for various aspects of early neuronal development, in part by promoting interkinetic nuclear migration in neuronal progenitors, and in the subsequent migration of the resulting postmitotic neurons (Del Bene ; Tsai ; Hu ; Markus ). Moreover, by mediating retrograde transport in neurons throughout their developmental progression, dynein is crucial for the maintenance of neuronal health, especially in motor neurons in which cargoes must be transported over very long distances (≤1 m) (Bowman ; Shah ; Wagner ; He ; Hendricks ; Fu and Holzbaur, 2013; Rao ). However, of note, our findings suggest that dynein itself is unaffected by the mutation; rather, dynein activity is indirectly affected by the reduced microtubule-binding affinity of a key regulatory MAP, She1. To date, a clear functional homologue of She1 in humans has not been identified. However, there indeed exists a myriad and complex network of MAPs in higher eukaryotes that may play roles similar to that of She1. For instance, the mammalian tau-related MAP4 protein, which binds in close proximity to G436 (Shigematsu ), has been implicated in the control of dynein-mediated spindle orientation during mitosis in mammalian cells (Samora ). MAP4 was also shown to physically interact with dynein–dynactin in vivo and to inhibit dynein-mediated microtubule gliding in vitro (Samora ). MAP4 has also been shown to shorten dynein-dependent runs of melanosomes in Xenopus melanophores (Semenova ). Another potential functional homologue of She1 is MAP9 (also known as ASter-Associated Protein, or ASAP), depletion of which disrupts spindle organization (Saffin ; Venoux ) and which was recently shown to inhibit processive motility of purified dynein–dynactin complexes by specifically precluding microtubule binding by dynactin (Monroy ). Thus, it will be important to determine how TUBA1AG436R affects binding of these important neuronal MAPs.

MATERIALS AND METHODS

Request a protocol through Bio-protocol.

Plasmids, yeast strain growth, and genetic manipulation

Strains used in this study were isogenic to either BY4742 (for Figures 1. 2, A and B, 4, and 5; MATα; ura3∆0 leu2∆0 his3∆1 lys2∆0; provided by euroscarf, http://www.euroscarf.de) or YEF473 (for Figures 3 and 6 – 8; ura3-52 lys2-801 leu2-∆1 his3-∆200 trp1-∆63). The TUB1 integrating plasmid, pCR2-TUB1, consists of the region of the TUB1 locus from the intron (situated close to the 5′ end of the gene) to 385 base pairs after the stop codon cloned into the pCR2 vector (Invitrogen). The HIS3 gene expression cassette was ligated into the BsrGI site within the 3′ untranslated region of the TUB1 sequence within pCR2 (pCR2-TUB1). The G437R mutation was subsequently introduced into pCR2-TUB1 by PCR, generating pCR2-tub1. For integration into the native TUB1 locus, pCR2-TUB1 (either wild type or mutant) was digested with SphI, transformed into yeast using the lithium acetate method, and transformants were selected on media lacking histidine. All transformants were confirmed by PCR and sequencing.

RFP-TUB1 and RFP-tub1 (under control of the TUB1 promoter; employed in Figures 1C and 5CE), are derived from pAF125 (Straight ), as previously described (Caudron ). In addition to this construct, we also generated pHIS3p:mRuby2-tub1::LEU2 to visualize microtubules in mutant cells (employed in Figure 3, C and D). To this end, we engineered the G437R point mutation into pHIS3p:mRuby2-TUB1+3′UTR::LEU2 (Markus ) using traditional molecular biological methods. For comparison of relative α-tubulin incorporation into mitotic spindles, we used yeast strains with similarly integrated mRuby2-α-tubulins (pHIS3p:mRuby2-TUB1+3′UTR::LEU2 or pHIS3p:mRuby2-tub1G437R+3′UTR::LEU2). To assess the relative incorporation of Tub3 into the mitotic spindle, we replaced the TUB1+3′UTR cassette in pHIS3p:mRuby2-TUB1+3′UTR::TRP1 (Markus ) with the TUB3 genomic sequence, including 150 base pairs of the 3′UTR (note that both mRuby2-TUB1 and mRuby2-TUB3 possess the same glycine–serine linker between the mRuby2 and the tubulin). This plasmid, pHIS3p:mRuby2-TUB3+3′UTR::TRP1, was digested with BbvCI and transformed into yeast using the lithium acetate method, and transformants were selected on media lacking tryptophan. Before imaging cells with these chromosomally integrated FP-Tub1 plasmids, cells were grown in synthetic defined complete media (i.e., histidine was indeed included in the growth media, omission of which would potentially lead to increased levels of expression from the HIS3 promoter [ Kim and Clark, 2002]). Vectors to generate GFP-Bim1 (pB1225) and Bik1-GFP (pB681) were kindly provided by D. Pellman (Dana-Farber Cancer Institute, Boston, MA; Tirnauer ; Lin ).

For the two-hybrid experiments, the TUB1 or tub1 open reading frames from the respective pCR2 vectors (see above) were cloned into the pLexA vector (Addgene) to produce LexADBD-Tub1 (or LexADBD-Tub1G437R) fusion proteins with a-tubulin and the DNA-binding domain of LexA (LexADBD). Bim1, Kip3, and She1 were amplified from genomic DNA and cloned into the pGADT7 vector (Invitrogen) to produce fusion proteins with the GAL4–activating domain (GAL4AD).

The 6His-tagged-She1Cter expression plasmid was constructed in the pET28 vector (Novagen). The She1 C-terminal part coding for amino acids 194–338 was ligated between the NdeI and XhoI sites of the vector downstream of the 6His and thrombin site.

To generate a GFP11x7-She1–expressing yeast strain (She1 fused to seven copies of strand 11 of GFP) (Kamiyama ), the GFP11x7 cassette was PCR amplified from pACUH:GFP11x7-mCherry-ß-tubulin (Addgene, plasmid # 70218) and integrated at the 5′ end of the SHE1 open reading frame using the sequential URA3 selection/5-FOA (5-fluoroorotic acid) counterselection method. To separately express strands 1–10 of the GFP barrel (GFP1-10, which is required to reconstitute fluorescence), we generated a plasmid with an expression cassette encoding GFP1-10 under the control of the strong TEF1 promoter (TEF1p), as well as the TRP1 selectable marker (pRS304:TEF1p:GFP1-10). We PCR amplified the TEF1p:GFP1-10::TRP1 cassette and integrated it into the lys2-801 locus using homologous recombination into the GFP11x7-She1–expressing yeast strain.

To express a second copy of TUB3 from the genome, the sequence corresponding to TUB3 and 153 nucleotides of the 3′ UTR was amplified from pHIS3p:mRuby2-TUB3+3′UTR::TRP1 (described above) and assembled into pRS306 digested with KpnI and NotI along with a second PCR product corresponding to the TEF1 promoter using isothermal assembly (Gibson ). This plasmid, pRS306: TEF1p:TUB3+3′UTR, was digested with ApaI (cuts within the URA3 gene, leading to integration at the ura3-52 locus) and transformed into yeast using the lithium acetate method, and transformants were selected on media lacking uracil.

To assess viability on solid media (Figure 1D), serial dilutions of fresh overnight cultures of wild-type or tub1 cells (three different haploid clones for each strain) were spotted onto solid yeast extract peptone adenine dextrose (YPAD) media with or without benomyl, as indicated. Plates were incubated for 2 d at 30°C.

Image acquisition and analysis

Cell imaging was performed on either a Zeiss Axiovert microscope equipped with a Cool Snap ES CCD camera (Ropper Scientific; for Figures 1, 2, and 4 and Supplemental Figures S3 and S4) or Nikon Ti-E microscope equipped with a 1.49 NA 100× total internal reflection fluorescence (TIRF) objective, a Ti-S-E motorized stage, piezo Z-control (Physik Instrumente), an iXon DU888 cooled EM-CCD camera (Andor), a stage-top incubation system (Okolab), and a spinning-disk confocal scanner unit (CSUX1; Yokogawa) with an emission filter wheel (ET525/50M for GFP and ET632/60M for mRuby2; Chroma; Figures 3, 7, and 8). For Figures 1, 2, and 4, 11 Z-planes with 0.3 μm spacing were captured using 2 × 2 binning (the exposure time varied between experiments). For Figures 3, 7, and 8, 15 or 17 Z-planes with 0.2 μm spacing were captured. TIRF microscopy (to image in vitro reconstituted microtubules from purified protein or cell extracts; Figures 6 and 7 and Supplemental Figure S5) was performed with a 1.49 NA 100× TIRF objective on a Nikon Ti-E inverted microscope equipped with a Ti-S-E motorized stage, piezo Z-control (Physik Instrumente), and an iXon X3 DU897 cooled EM-CCD camera (Andor). Lasers (488, 561, and 640 nm) (Coherent) were used along with a multipass quad filter cube set (C-TIRF for 405/488/561/638 nm; Chroma) and emission filters mounted in a filter wheel (525/50, 600/50, and 700/75 nm; Chroma).

For in vivo microtubule dynamics measurements, maximum-intensity projection images of Bik1-GFP–expressing cells were used. Ten-minute movies were acquired with an acquisition frequency of six frames per minute. Microtubule lengths at each time point were measured manually from maximum-intensity projections, and microtubule dynamic parameters were calculated as described (Kosco ), using an in-house Visual Basic macro in Excel (Caudron ). We measured background-corrected She1, Tub1, or Tub3 spindle-localized fluorescence from maximum-intensity projections using ImageJ (National Institutes of Health). Tub1-corrected She1 intensities were calculated by normalizing the fluorescence intensity values of each (She1, Tub1, and Tub3) to 1 (by dividing the raw mean background-corrected values for that measured in wild-type or tub1 cells by the wild-type value) and then dividing the resulting normalized She1 values by the normalized Tub1 value for wild type and tub1, respectively. To additionally correct for Tub3 intensities, these Tub1-corrected values were then divided by the normalized Tub3 values (as calculated above; in which wild type = 1 and tub1 = 1.91).

To assess spindle dynamics parameters, we determined spindle position in cells over time by clicking the center of a preanaphase spindle in each frame and calculating the displacement between frames using an in-house–developed ImageJ macro. Microtubule lengths during sliding events were manually measured at each time point from maximum-intensity projections. Catastrophe evens were defined as “following a sliding event” (Figure 4E) if they occurred during the 1 min period following the cessation of a sliding event. The spindle position with respect to the cell boundaries, as shown in Figure 4G, was determined for spindles with a pole-to-pole length of 0.8–1.2 μm from the first frames of movies of G2/M cells. The quantification was done blind to the genotype. At least 52 preanaphase spindles from three independent clones were measured for each strain, as described (DeZwaan ). Spindle positioning was similarly determined from single time-point images acquired of hydroxyurea-arrested cells for data shown in Supplemental Figure S6C.

Assessment of cell cycle progression (see Figure 8) was performed by imaging cells in the CellAsic ONIX system using microfluidic cassettes designed for haploid yeast cells (Y04C; MilliporeSigma) on a spinning-disk confocal scanner unit (CSUX1; Yokogawa) with an emission filter wheel (ET525/50M for yellow fluorescent protein [YFP]) using a 100× oil-immersion objective. In brief, after an overnight growth in synthetic defined (SD) complete media (supplemented with 2% glucose) at 30°C, cells were diluted twofold and grown for 5 h before a 50-fold dilution into the cell inlet well of the microfluidic cassette, which was primed with SD complete before the addition of cells (per the manufacturer’s instructions). Pressure was maintained at 7.0 psi throughout the imaging period to ensure a constant replenishment of media into the cassette, which was set to 30°C. Wild-type and mutant cells were imaged simultaneously by introducing respective cells into adjacent imaging chambers of the microfluidics cassette. Z-stacks (seven steps with 0.5 µm spacing) from five XY coordinates for each strain were acquired for 10–12 h at 90 s intervals.

Cell lysis and immunoblotting

Yeast cultures were grown overnight at 30°C in 3 ml of YPAD. The next morning, 1 ml of overnight culture was added to 2 ml fresh YPAD and grown at 30°C for 1.5 h before harvesting. Equal numbers of cells were pelleted and resuspended in 0.2 ml of 0.1 M NaOH and incubated for 5 min at room temperature as described (Kushnirov, 2000). After centrifugation, the resulting cell pellet was resuspended in sample buffer and heated to 100°C for 3 min. After clarification (1 min at 15,000 rpm), lysates were separated on a 10% SDS–polyacrylamide gel. Before electroblotting to polyvinylidene fluroride (PVDF) (for 32 min at 100 V in 25 mM Tris, 192 mM glycine supplemented with 0.05% SDS and 10% methanol), acrylamide gels were imaged for total protein using Bio-Rad Stain-Free technology (on a Bio-Rad Chemidoc gel documentation system). The fluorescence intensity of these bands was used to correct for differences in potential loading differences in each lane. PVDF membranes were probed with 1:2000 rat (YL1/2; in-house production) or 1:100 mouse (4A1; registry AB_2732839 from DSHB) anti–α-tubulin antibodies, and either horseradish peroxidase–conjugated goat anti-rat (Jackson ImmunoResearch Laboratories 712-605-153) or IRDye 800CW goat anti-mouse antibodies (Li-Cor 925-32210) used at 1:2000 and 1:15,000, respectively. Chemiluminescence signals were acquired on a Bio-Rad Chemidoc MP, and fluorescence signals were acquired on an Odyssey CLx imaging system. Immunoblots were imaged without saturating the camera’s pixels. Band intensity and background correction was done using ImageJ for both chemiluminescence and fluorescence. Bio-Rad Stain-Free gel signal was used to correct for differences in lysate loading between lanes.

Electron tomography of yeast cells

Cells were processed for electron microscopy using methods described previously (Winey ; Giddings ). Briefly, aliquots of log phase cultures were collected by vacuum filtration and frozen using a Wohlwend Compact 02 high-pressure freezer (Technotrade International, Manchester, NH). The frozen cells were freeze-substituted in 1% osmium tetroxide and 0.1% uranyl acetate in acetone and then embedded in Epon/Araldite resin (Electron Microscopy Sciences, Fort Washington, PA). Serial semthick (250 nm) sections were cut using a Leica Ultracut-E microtome and collected onto Formvar-coated copper slot grids. The sections were poststained with 2% aqueous uranyl acetate followed by Reynolds lead citrate. Fifteen-nanometer colloidal gold particles (Ted Pella) were affixed to both surfaces of the section to serve as fiducial markers for tilt-series alignment.

Tomography was performed as described (O’Toole ). Dual-axis tilt series were collected using a Tecnai F30 microscope (ThermoFisher Scientific, Waltham, MA) using the SerialEM program for data acquisition (Mastronarde, 2005). Tilt-series data were acquired from serial sections at a pixel size of 1.2 nm using a Gatan One View camera (Gatan, Pleasanton, CA). Tomographic volumes were computed using the IMOD software package (Kremer ; Mastronarde, 1997). For each spindle, volumes from three to four serial sections were joined, and the spindle microtubules were modeled using the 3dmod program of the IMOD software package. Microtubule number, lengths, and SPB diameters were computed from the model contour data. The mtpairing program of the IMOD software package was used to compute and identify the core bundle mts in each spindle (Winey ). In total, two spindles from wild-type cells, two spindles from tub1 cells, and five spindles from “Tub3-only” (TEF1p :TUB3 tub1∆) cells were reconstructed and analyzed.

Production of recombinant protein

The 6His-She1Cter plasmid was transformed into Rosetta pLysS bacteria. For protein production, bacterial cultures grown in M9 medium were induced by the addition of 1 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) overnight at 18°C. The clarified lysate was separated on a cation exchange column (SP GE healthcare), and bound protein was eluted in cation elution buffer (500 mM NaCl, 40 mM Tris, pH 9.2) and then applied to a NiNTA column (Qiagen) after the addition of 20 mM imidazole. After elution in NiNTA elution buffer (300 mM NaCl, 20 mM Tris, pH 7.5, 250 mM imidazole), the protein was simultaneously concentrated and buffer-exchanged (with a Vivaspin Turbo 4; Sartorius) into PM buffer (80 mM PIPES, pH 6.8, 1 mM MgCl2, 0.2% NP40).

Purification of yeast tubulin was performed essentially as described (Johnson ) with minor modifications. Yeast cells (JEL1) cotransformed with p426Gal1:Tub1 (or p426Gal1:Tub1G437R) and p424:Tub2-6His were grown in 5 ml of selective SD complete media (lacking uracil and tryptophan) supplemented with 2% glucose for 3 d at 30°C before being transferred to 50 ml of identical media for 1 d. The 50 ml cultures were then transferred to 1 l of nonselective YPGL (2% peptone, 1% yeast extract, 3% glycerol, and 2% lactate; note that we grew 16 l of cells for a typical prep). When the cell density reached an OD600 between 5 and 9 (approximately 20–24 h later), 20 g of galactose powder was added per liter of YPGL, and after 5 h, cells were harvested, washed with water, and stored at –80°C. Cells (approximately 75 g) were thawed and resuspended in 70 ml of lysis buffer (50 mM HEPES, pH 7.4, 500 mM NaCl, 10 mM MgSO4, 30 mM imidazole) supplemented with 50 µM GTP and cOmplete protease inhibitor cocktail (Roche) and lysed by five to six passes through a microfluidizer (LM10; Microfluidics) at 23,000 psi, with 5 min on ice between each pass. After clarification (at 13,000 rpm for 30 min at 4°C), the supernatant was applied to a 5 ml HisTrap Ni-NTA column (GE) preequilibrated with 10 column volumes (CVs) of lysis buffer supplemented with GTP using an AKTA FPLC (GE). After washing the column with 10 CVs of lysis buffer supplemented with 50 µM GTP and 10 CVs of nickel wash buffer (25 mM PIPES, pH 6.9, 1 mM MgSO4, 30 mM imidazole) supplemented with 50 µM GTP, bound protein was eluted with six CVs of elution buffer (25 mM PIPES, pH 6.9, 1 mM MgSO4, 300 mM imidazole) supplemented with 50 µM GTP. Peak fractions (determined by absorbance at 260 nm) were pooled and treated with nuclease (Pierce Universal Nuclease; catalogue #88702; 10 µl per 20 ml of eluate) for 15 min at room temperature and then diluted with MonoQ buffer A (25 mM PIPES, pH 6.9, 2 mM MgSO4, 1 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) supplemented with 50 µM GTP such that the final imidazole concentration was 100 mM. The protein was then loaded onto a MonoQ 10/100GL anion exchange column preequilibrated with five CVs of 90% MonoQ buffer A (see above) and 10% MonoQ buffer B (25 mM PIPES, pH 6.9, 2 mM MgSO4, 1 mM EGTA, 1 M NaCl) supplemented with 50 µM GTP, after which bound protein was eluted using with a 10–70% MonoQ buffer B gradient over 50 CVs. Peak tubulin fractions (determined by absorbance at 260 nm and SDS–PAGE) were pooled and concentrated (Amicon Ultra-4 30K; catalogue #UFC803024) to approximately 2.8–3.0 µM (concentration and aggregation were closely monitored using absorbance at 260 and 280 nm) and then dialyzed against tubulin storage buffer (10 mM PIPES, pH 6.9, 1 mM MgSO4, 1 mM EGTA) supplemented with 50 µM GTP (Thermo Slide-A-Lyzer; catalogue #66810). The resulting protein was aliquoted (50 µl), snap frozen in liquid nitrogen, and stored at –80°C.

We purified She1-HaloTag from protease-deficient budding yeast transformed with pBJ1153:ARSH/CEN:GAL1p:8xHis-ZZ-2xTEV-She1-HaloTag. Cells were grown at 30°C in 3 ml YPA media supplemented with 2% glucose and 100 µg/ml G418 (to select for the plasmid) for 16 h. The 3 ml culture was transferred to 40 ml YPA media supplemented with 2% glucose and 100 µg/ml G418 and grown at 30°C for 8 h before being transferred to 1 l YPA media supplemented with 2% raffinose and 100 µg/ml G418. After 16 h at 30°C, the cells were transferred to sterile centrifuge bottles and centrifuged to remove media. Cells were then resuspended in 1 l YPA media supplemented with 2% galactose and 100 µg/ml G418 and grown at 30°C for 5–6 h before harvesting, washing with water, and storing at –80°C. Cells were thawed in a 0.5 volume of cold 2× lysis buffer (1× buffer: 30 mM HEPES, pH 7.2, 50 mM potassium acetate, 2 mM magnesium acetate, 0.2 mM EGTA, 10% glycerol, 1 mM dithiothreitol (DTT), and protease inhibitor tablets [Pierce]) and then lysed by five passes through a microfluidizer (LM10; Microfluidics) at 23,000 psi, with 5 min on ice between each pass. The lysate was clarified at 22,000 × g for 20 min, adjusted to 0.005% Triton X-100, and then incubated with immunoglobulin G Sepharose agarose beads for 1 h at 4°C. The resin was then washed three times with wash buffer (30 mM HEPES, pH 7.2, 50 mM potassium acetate, 2 mM magnesium acetate, 0.2 mM EGTA, 300 mM KCl, 0.005% Triton X-100, 10% glycerol, 1 mM DTT, protease inhibitor tablets) and twice in TEV digest buffer (10 mM Tris, pH 8.0, 150 mM KCl, 0.005% Triton X-100, 10% glycerol, 1 mM DTT). To fluorescently label She1-HaloTag, the bead-bound protein was incubated with 6.7 µM HaloTag-TMR ligand (Promega) for 15 min at room temperature. The resin was then washed three more times in TEV digest buffer to remove unbound ligand and then incubated in TEV buffer supplemented with TEV protease for 1 h at 16°C. The resulting eluate was collected using a centrifugal filter unit (0.1 µm; Millipore), aliquoted, drop frozen in liquid nitrogen, and stored at –80°C.

Liquid chromatography–coupled tandem mass spectrometry

Approximately 10 µg of purified wild-type or G437R mutant tubulin (purified as described above from budding yeast) was denatured, reduced, and alkylated in freshly prepared 5% (wt/vol) SDS, 10 mM tris(2-carboxyethyl-phosphine) (TCEP), and 40 mM 2-chloroacetamide (ClAA) by boiling for 10 min at 95°C. Sample preparation for mass spectrometry analyses was performed using the SP3 method (Hughes ). Briefly, Sera-Mag SpeedBead carboxylate-modified magnetic beads (200 µg; Cytiva) were added to denatured and reduced tubulin samples and then mixed thoroughly. Acetonitrile was added to 80% (vol/vol) and mixed for 10 min to precipitate protein. Tubes were placed on a magnet, and the supernatant was removed. Beads were then washed two times with 80% (vol/vol) ethanol and two times with 100% acetonitrile, by incubating in a sonicating water bath for 2 min per wash. Protease digestion was performed with 0.5 µg of a LycC/Trypsin mix (Promega) in 25 µl 50 mM Tris, pH 8.5, with mixing overnight at 37°C. To remove the buffer from the tryptic peptides, acetonitrile was added to 95% (vol/vol) to precipitate peptides. One wash with 100% acetonitrile was performed, and tryptic peptides were eluted twice with 1% (vol/vol) trifluoroacetic acid (TFA), 3% (vol/vol) acetonitrile in LC/MS grade water. Elutions were dried using a speed-vac rotatory evaporator and resuspended in 0.1% TFA, 3% acetonitrile in water. Peptides were directly injected onto a Waters M-class column (1.7 µm, 120 A, rpC18, 75 µm × 250 mm) and gradient eluted from 2% to 40% acetonitrile over 40 min at 0.3 µl/min using a Thermo Ultimate 3000 UPLC (Thermo Scientific). Peptide ions were detected with a Thermo Q-Exactive HF-X mass spectrometer (Thermo Scientific) scanning MS1 spectra at 120,000 resolution from 380 to 1580 m/z with a 45 ms fill time and 3E6 AGC target. The top 12 most intense peaks were isolated with 1.4 m/z window with a 100 ms fill time and 1E6 AGC target and 27% HCD collision energy for MS2 spectra collected at 15,000 resolution. Dynamic exclusion was enabled for 5 s. MS data raw files were searched against the Uniprot Saccharomyces cerevisiae database UP000002311 (downloaded on 4/16/2021) using Maxquant 1.6.14.0 with cysteine carbamidomethylation as a fixed modification, while methionine oxidation and protein N-terminal were set as variable modifications. The mass tolerances for the database search were 4.5 ppm for the MS1 precursors and 20 ppm for the MS2 fragment ions; the minimum peptide length was seven residues. Peptide and protein level false discovery rate was 0.01.

Pull-down experiments

For She1Cterm-tubulin pull-down experiments, 2.5 µg of purified tubulin (from cow brain) was incubated with or without 2.5 µg of 6His-She1Cter in 500 µl of PM buffer. After 30 min at room temperature, NiNTA beads (10 µl) were added (Thermo Fisher). After a 10 min incubation, the beads were washed three times with PM buffer and then boiled for 5 min in 60 µl of sample buffer before SDS–PAGE analysis. For peptide competition experiments, 50 µg of each peptide (dissolved in PM buffer; wild type: EEGEFTEAREDLAA­LERDYIEVADSYAEEEEF; G437R: EEGEFTEAREDLAALERDYIEV­ADSYAEEEEF) was added to the mixture of She1C-term (0.25 µg; resulting in an approximately 900-M excess of peptide with respect to She1C-term) and tubulin (1.25 µg) and allowed to bind for 30 min at room temperature. Then, NiNTA beads (10 µl) were added (Thermo Fisher), incubated for 10 min, washed three times with PM buffer, and then boiled for 5 min in 60 µl of sample buffer before SDS–PAGE and immunoblot blot analysis. For immunblotting, the gel was transferred to a PVDF membrane (BioRad TransBlot Turbo), blocked with phosphate-buffered saline supplemented with 5% milk for 30 min, and then probed with anti–α-tubulin (YL1/2 1:10,000) followed by Cy5 anti-rat secondary antibody (Jackson ImmunoResearch; 1:2000). To quantify the tubulin signals, the local background was subtracted and signals were normalized such that tubulin-bound 6His-She1Cter without peptide was equal to 100. The average of two replicates is presented in the graph (Figure 6C).

Microtubule reconstitutions using cell lysates

Microtubules were polymerized from preassembled coverslip-immobilized microtubule seeds and concentrated cell extracts as previously described (Bergman ), but with minor modifications. Overnight cultures of cells (3 ml in YPAD media) with respective α-tubulin content (e.g., wild type, tub1) were diluted into 200 ml of YPAD and grown for 16 h before being transferred to 800 ml of YPAD. Cultures were grown for 30 min before treatment with 100 mM hydroxyurea (to synchronize the cells in a cell cycle amenable to microtubule polymerization activity). After a 2.5 h incubation in hydroxyurea, cells were pelleted, washed once with water, then drop frozen in liquid nitrogen after removing residual liquid, and stored at –80°C until lysis. Frozen cells (approximately 4 g) were lysed in a prechilled midsize cryogenic impact mill (SPEX model 6875). Milling consisted of a 3 min prechill followed by 10 cycles comprising 3 min of grinding at 30 impacts per second (15 cps) and 1 min of rest. The sample vial remained submerged in liquid nitrogen throughout the lysis process. Frozen, powdered lysate was recovered and stored at –80°C until use.

Microtubule seeds were prepared by incubating a mixture of unlabeled and rhodamine-labeled porcine tubulin (Cytoskeleton; resuspended at 5 and 1 mg/ml, respectively, in PEM80: 80 mM PIPES, pH 6.9, 1 mM EGTA, 1 mM MgCl2) with 1 mM GMPCPP (Jena Biosciences) at 37°C for 10 min. Microtubule seeds were adhered to imaging chambers assembled from a glass slide, double-stick tape, and a plasma-cleaned and silanized glass coverslip using an anti-rhodamine antibody (1:10 dilution incubated for 10 min; Thermo Fisher; catalogue #200-301-246). Seeds were diluted 1:100 in MT seed mix (PEM80, 5 mg/ml casein, oxygen scavenging mix, 5 mM β-mercaptoethanol, 0.4% methylcellulose). Following antibody incubation, the chamber was washed with wash buffer (PEM80 supplemented with oxygen scavenging mix and 5 mM β-mercaptoethanol) before adding diluted see mix. Seeds were incubated for approximately 5 min before an additional wash with wash buffer, after which the chamber was ready for addition of lysate.

To prepare lysate, 0.5 µl of Protease Inhibitor Cocktail IV (Calbiochem) was added to approximately 0.5 g of frozen powdered lysate that was transferred to a liquid nitrogen prechilled polycarbonate ultracentrifuge tube. After thawing on ice for 10 min, the lysate was then clarified by centrifuging at 346,000 × g for 25 min at 4°C (in a TLA-100 rotor). To polymerize microtubules, lysate supplemented with 0.5 mM GTP (from 20 mM GTP stock) was introduced into the chamber and incubated for 15 min in a stage-top incubator prewarmed to 28°C. Microtubule growth from coverslip-adhered seeds was monitored by interference fluorescence microscopy (IRM; see Supplemental Figure S5D) as described previously (Mahamdeh ). To assess She1–microtubule binding, 1 µl of full-length She1-HaloTag660 diluted in 7 µl of clarified lysate (supplemented with 0.5 mM GTP) was then introduced into the imaging chamber with the polymerized microtubules (note that each chamber accommodates approximately 7–8 µl in volume; thus, ∼1 chamber volume of She1-supplemented lysate was introduced into each chamber). Lysate was used instead of buffer to ensure that sufficient tubulin concentrations were present to prevent coverslip-immobilized microtubules from depolymerizing. Images of She1-HaloTag660, microtubules (acquired using IRM; see Supplemental FigureS5D, for example) and rhodamine seeds were acquired using TIRF microscopy immediately following addition into a chamber (all images were acquired within 3 min of adding She1). Using ImageJ, lines drawn along the length of single, nonbundled microtubules (identified in the IRM channel) were used to determine the mean fluorescence intensity per pixel. Overlapping and/or intersecting microtubules were omitted from our measurements, as were microtubule seed regions, to which we noted She1 binds to a significantly lower extent (e.g., see arrowheads in Figure 6D). Approximately four to six different fields were acquired to control for potential variation between fields of view. To control for potential regional She1 concentration differences within each chamber, images were generally acquired within the middle of each, a significant distance from the sample loading area. Note that replicates were performed on different days.

Structural analyses and mutation modeling

Molecular graphics and analyses were performed with the UCSF Chimera package. The rotamers function was used to model an arginine substitution into position 436 of the α-tubulin structure (PDB 3J6G). The top four rotamers were selected for visualization (see Supplemental Figure S2).

Click here for additional data file.

Click here for additional data file.